Bhise, K.; Sau, S.; Kebriaei, R.; Rice, S.A.; Stamper, K.C.; Alsaab, H.O.; Rybak, M.J.; Iyer, A.K.
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA. Materials 2018, 11, 1245.
https://doi.org/10.3390/ma11071245
AMA Style
Bhise K, Sau S, Kebriaei R, Rice SA, Stamper KC, Alsaab HO, Rybak MJ, Iyer AK.
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA. Materials. 2018; 11(7):1245.
https://doi.org/10.3390/ma11071245
Chicago/Turabian Style
Bhise, Ketki, Samaresh Sau, Razieh Kebriaei, Seth A. Rice, Kyle C. Stamper, Hashem O. Alsaab, Michael J. Rybak, and Arun K. Iyer.
2018. "Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA" Materials 11, no. 7: 1245.
https://doi.org/10.3390/ma11071245
APA Style
Bhise, K., Sau, S., Kebriaei, R., Rice, S. A., Stamper, K. C., Alsaab, H. O., Rybak, M. J., & Iyer, A. K.
(2018). Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA. Materials, 11(7), 1245.
https://doi.org/10.3390/ma11071245